☆ 4.5 Article

Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021

EUROSURVEILLANCE (2021)

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021

Iivo Hetemaki et al.

Summary: An outbreak caused by the SARS-CoV-2 Delta variant spread from one inpatient in a secondary care hospital to three primary care facilities, resulting in a significant number of infections and deaths. Despite the use of personal protective equipment by healthcare workers and high COVID-19 vaccination coverage, transmission still occurred.

EUROSURVEILLANCE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health